NJ Pain-Drug Maker Hits Ch. 11 With $75M Purchase Offer
New Jersey pain-drug maker Pernix Therapeutics LLC and its subsidiaries landed in Delaware bankruptcy court Monday, which the company attributed to declining revenues, with a $75.6 million purchase offer from a hedge...To view the full article, register now.
Already a subscriber? Click here to view full article